losartan has been researched along with Rhabdomyolysis in 2 studies
Losartan: An antagonist of ANGIOTENSIN TYPE 1 RECEPTOR with antihypertensive activity due to the reduced pressor effect of ANGIOTENSIN II.
losartan : A biphenylyltetrazole where a 1,1'-biphenyl group is attached at the 5-position and has an additional trisubstituted imidazol-1-ylmethyl group at the 4'-position
Rhabdomyolysis: Necrosis or disintegration of skeletal muscle often followed by myoglobinuria.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The clinical course of losartan potassium/hydrochlorothiazide (Preminent(®))-induced hyponatremia has not been described." | 7.77 | Losartan potassium/hydrochlorothiazide (Preminent®) and hyponatremia: case series of 40 patients. ( Fujiki, K; Kinoshita, H; Kobayashi, K; Koga, N; Tomiyama, J; Yaguramaki, T; Yakushiji, F; Yasuda, M, 2011) |
| "The clinical course of losartan potassium/hydrochlorothiazide (Preminent(®))-induced hyponatremia has not been described." | 3.77 | Losartan potassium/hydrochlorothiazide (Preminent®) and hyponatremia: case series of 40 patients. ( Fujiki, K; Kinoshita, H; Kobayashi, K; Koga, N; Tomiyama, J; Yaguramaki, T; Yakushiji, F; Yasuda, M, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Uchiyama, H | 1 |
| Tsujimoto, M | 1 |
| Shimada, N | 1 |
| Tsutsui, K | 1 |
| Nitta, A | 1 |
| Yoshida, T | 1 |
| Furukubo, T | 1 |
| Izumi, S | 1 |
| Yamakawa, T | 1 |
| Tachiki, H | 1 |
| Minegaki, T | 1 |
| Nishiguchi, K | 1 |
| Kinoshita, H | 1 |
| Kobayashi, K | 1 |
| Yaguramaki, T | 1 |
| Yasuda, M | 1 |
| Fujiki, K | 1 |
| Tomiyama, J | 1 |
| Koga, N | 1 |
| Yakushiji, F | 1 |
2 other studies available for losartan and Rhabdomyolysis
| Article | Year |
|---|---|
Evaluation of Trace Elements in Augmentation of Statin-Induced Cytotoxicity in Uremic Serum-Exposed Human Rhabdomyosarcoma Cells.
Topics: Cell Line, Tumor; Cell Survival; Cisplatin; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; | 2018 |
Losartan potassium/hydrochlorothiazide (Preminent®) and hyponatremia: case series of 40 patients.
Topics: Aged; Aged, 80 and over; Antihypertensive Agents; Drug Combinations; Female; Humans; Hydrochlorothia | 2011 |